AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-385511 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 8, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
16,119
Total Value
$97,323.13
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 3, 2026 | Sale | 2,877 | $6.07 | $17,462.81 | 562,715 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Sep 3, 2026 | Sale | 3,223 | $6.07 | $19,562.97 | 630,644 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Sale | 4,725 | $6.02 | $28,436.47 | 557,990 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Sale | 5,294 | $6.02 | $31,860.88 | 625,350 | Indirect | See footnotes | View Details |